// App-Quantinova.ai

PB1081 : Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing and Diagnosis of von Willebrand Disease

Researchers

Presenter

  • K. Lee

Principal Investigators

  • J. Ross

  • P. Christopherson

  • I. Corrales

  • J. Eikenboom

  • K. Friedman

  • M. Springer

  • J. Johnsen

  • D. Lillicrap

Medical Centers

  • University of North Carolina, Chapel Hill, North Carolina, United States

  • Blood Research Institute, Milwaukee, Wisconsin, United States

  • Banc de Sang i Teixits; Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Catalonia, Spain

  • University of Michigan Medical School, Ann Arbor, Michigan, United States

  • 1VarmX, Leiden, The Netherlands. 2Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands., Leiden, Zuid-Holland, Netherlands

  • Versiti Blood Center of Wisconsin, Milwaukee, WI, United States

  • University of Hull, Hull, England, United Kingdom

  • University of Washington; Bloodworks Northwest, Seattle, Washington, United States

  • Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada

Locations

  • United States

  • Spain

  • Netherlands

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • National Human Genome Research Institute

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved